- $2.27bn
- $3.31bn
- $4.10bn
- 86
- 92
- 78
- 98
Annual income statement for ASGN, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,010 | 4,581 | 4,451 | 4,100 | 3,980 |
| Cost of Revenue | |||||
| Gross Profit | 1,142 | 1,370 | 1,280 | 1,184 | 1,149 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 3,659 | 4,172 | 4,087 | 3,795 | 3,750 |
| Operating Profit | 351 | 410 | 364 | 304 | 230 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 313 | 364 | 298 | 240 | 163 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 232 | 267 | 219 | 175 | 114 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 410 | 268 | 219 | 175 | 114 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 410 | 268 | 219 | 175 | 114 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.33 | 5.2 | 4.5 | 3.83 | 3.5 |